Company / FCF Margin
Revolution Medicines, Inc. FCF Margin History
FY2018-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-3094.1%
FY2023
5-year range
-3094.1% / -104.3%
FY2019-FY2023
Trend
-1191.3%
vs FY2022
Sector context
#128 of 133
Health Care
What the data says
FCF Margin changed -1191% YoY in FY2023, a notable deviation from the 4-year average annual change of -2142%.
Based on SEC 10-K filings.
-3094.1% in FY2023 with a 5-year CAGR of -3092.7%.
Declined from -104.3% to -3094.1% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -3092.7pp
- 5-Year Change
- -3092.7pp
- 10-Year Change
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 133This company -3094.1% Sector average -632.8%
▼
-388.9% below sector average
Key checks
Key Insights
- Revolution Medicines, Inc.'s fcf margin has declined for 3 consecutive years.
- In FY2023, fcf margin decreased 1191.3% year-over-year.
- Currently 2461.3pp below the Health Care sector average.
- Peak fcf margin was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | -3094.1% | -1191.3% |
| FY2022 | -239.6% | -129.7% |
| FY2021 | -104.3% | -7246.5% |
| FY2020 | -1.4% | - |
| FY2019 | - | - |
| FY2018 | -1.4% | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026